CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS AMENDMENT NO. 1 TO PRODUCT LICENSE AND ASSIGNMENT AGREEMENTProduct License and Assignment Agreement • November 14th, 2007 • Cytogen Corp • Pharmaceutical preparations
This Amendment No. 1 to that certain Product License and Assignment Agreement (this “Amendment”) is made and entered into as of August 30, 2007 by and among CYTOGEN CORPORATION, a Delaware corporation having an address at 650 College Road East, Suite 3100, Princeton, New Jersey 08540, United States (“Cytogen”), INPHARMA AS, a Norwegian company having an address at Pb 2030 (Konnerudgt. 27), 3003 Drammen, Norway (“Inpharma Norway”), and INPHARMA, INC., a Delaware corporation having an address at 101 Federal Street, Suite 1900, Boston, Massachusetts 02110 (“Inpharma USA,” together with Inpharma Norway, “Inpharma”).
